Endo International Adds Board Members
The global specialty pharma company Endo International PLC has appointed Douglas S. Ingram and Todd B. Sisitsky to its board of directors. Ingram brings 20 years of biotech and pharma experience to the business, and is currently the CEO of Chase Pharmaceuticals Corporation. He was previously president of Allergan Inc., a role which he left last March. Sisitsky is the managing partner of TPC Capital and a member of the TPB executive committee, co-leading the firm’s investment activities in the healthcare services and pharma/medical device sectors.